Streetbeat News

Regulatory

IBIT

Cryptocurrency markets are rallying ahead of the Trump-Biden U.S. Presidential election debate, with a Solana spot ETF application by VanEck as a key catalyst. Bitcoin, Ethereum, and Dogecoin are among the gainers. Notable developments include BlackRock's purchase of Bitcoin for its Global Allocation Fund and Coinbase suing the SEC and FDIC. Analysts caution about potential liquidations if Bitcoin drops to $60,700.

Portfolio Pulse from Khyathi Dalal

June 27, 2024 | 8:21 pm

DVAX

Dynavax has initiated a Phase 1/2 study for its novel shingles vaccine, Z-1018, to evaluate its safety, tolerability, and immunogenicity.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 8:10 pm

ACST

Acasti Pharma has reached 50% enrollment in its pivotal Phase 3 STRIVE-ON safety trial. This milestone is significant for the company's development of its lead drug candidate, GTX-104, aimed at treating subarachnoid hemorrhage. The trial's progress is a positive indicator for the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 8:06 pm

QUBT

Quantum Computing Inc. (QUBT) has received a notice from Nasdaq indicating that it has failed to meet the standard for continued listing. This could have significant implications for the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 8:01 pm

ERJ

The FAA reported that an Embraer business jet went off the runway at Newark Airport, causing a temporary runway closure.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:46 pm

CNI

Canadian National Railway (NYSE:CNI) shares traded lower following a train derailment in Matteson, Illinois. No injuries were reported, but a 'white powdery substance' was seen leaking. Residents are under a mandatory evacuation order. CNI shares have decreased by 2.53% in the past year and are down 0.76% at $117.34.

Portfolio Pulse from Erica Kollmann

June 27, 2024 | 7:45 pm

MRK

SNY

The CDC's Advisory Committee on Immunization Practices (ACIP) has unanimously voted to add Merck and Sanofi's pediatric hexavalent combination vaccine to the preferential recommendation list for preventing invasive Hib disease in American Indian and Alaska Native infants. The recommendation will become official once reviewed and finalized by the CDC Director and the Department of Health and Human Services.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:40 pm

FUN

SIX

Cedar Fair shares are trading higher after the company announced that the regulatory conditions for its merger of equals with Six Flags Entertainment have been satisfied.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:23 pm

SPY

IMF's Georgieva advises the U.S. Federal Reserve to lower policy rates only after clear evidence of inflation returning to the 2% target. The IMF's U.S. inflation forecast is slightly more optimistic than the Fed's. Additionally, U.S. consumer spending boost from COVID-era wealth may be subsiding, easing inflation pressure.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:21 pm

DHR

The FDA has granted marketing authorization to Cepheid for its Xpert HCV test and GeneXpert Xpress System, marking the first point-of-care Hepatitis C RNA test. This development is significant for Cepheid and its parent company, Danaher Corporation (DHR).

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:16 pm